See Neuraxpharm’s sites
FDFs | LESVI
APIs | INKE
Leading inhalation APIs expert Inke to triple production capacity
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
Inke to sponsor the virtual Drug Delivery to the Lungs Conference 2021
Inke is sponsoring Drug Delivery to the Lungs (DDL2021) Conference 2021
Corporate announcement: COVID-19 update
Corporate announcement: Update concerning novel coronavirus (COVID-19)
Inke to exhibit at the Drug Delivery to the Lungs (DDL) Conference 2019 in Edinburgh
at DDL2019 in Edinburgh,
11th to 13th December, to celebrate 30 years of Drug Delivery to the Lungs (DDL) Conference.
Inke exhibits at the Inhalation Asia 2019 in Hong Kong
Inke is attending Inhalation Asia 2019 in Hong Kong on the 13th – 15th November. The once every two years exhibition will take place at the Hong Kong Science and Technology Park, in Sha Tin.